Question · asked by 1 review

Specific allergen immunotherapy vs no immunotherapy: Participant or parent‐rated eczema severity using a published scale

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
Specific allergen immunotherapy vs no immunotherapy
Participant or parent‐rated eczema severity using a published scale · adults and children with atopic eczema and inhalant allergen sensitisation
Specific allergen immunotherapy for the treatment of atopic eczema (2016) · Cochrane Headline outcomes only
no estimate extracted2 studies · 184 participantsLow

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Specific allergen immunotherapy for the treatment of atopic eczema
2016 · Cochrane Headline outcomes only
Not reportedlist not extracted yetNot assessed

Studies behind the findings

None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.